ReviewPlant foods for human nutrition (Dordrecht, Netherlands)2025
Erythrina edulis (Pajuro): An Undervalued Alternative for the Generation of Bioactive Peptides with Nutraceutical Properties.
Review in Plant foods for human nutrition (Dordrecht, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of VAYPQCV, a Gastrointestinally Stable Competitive DPP-IV Inhibitory Peptide from Bitter Leaf (Vernonia amygdalina).Plant foods for human nutrition (Dordrecht, Netherlands) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Erythrina edulis (pajuro) is a native Andean legume with promising nutritional and functional properties. Its seeds possess high-quality protein content and a favorable amino acid profile, characterized by residues such as Trp, Tyr, Phe, Leu, Ile, Val, Pro, and Gly, which are critical precursors of bioactive peptides. Upon enzymatic hydrolysis, these residues contribute to diverse bioactivities, including antioxidant (Trp, Tyr), antihypertensive (Pro at the C-terminal), and antidiabetic (branched-chain residues at the N-terminal) functions, making it a valuable source for bioactive peptide production. This review highlights current evidence regarding the nutraceutical potential of peptides derived from E. edulis proteins, especially those generated via enzymatic hydrolysis and simulated gastrointestinal digestion. Based on a systematic literature search in Scopus, Web of Science, and Google Scholar, this review highlights that these peptides exhibit a broad spectrum of biological activities, including antioxidant, antihypertensive, antidiabetic, immunomodulatory, neuroprotective, and anti-obesity effects, and are largely associated with low-molecular-weight fractions. The multifunctional nature of these peptides, together with E. edulis's rich composition of polyphenols, flavonoids, and essential minerals, supports their consideration as sustainable ingredients in functional food development. However, limitations such as a lack of in vivo studies, challenges in process scalability, and underutilization of the crop remain. Future perspectives emphasize the integration of biotechnological tools, including ultrasound-assisted hydrolysis and bioinformatics-guided peptide design, to enhance bioactivity discovery and application. This review provides a foundation for the revalorization of E. edulis as a source of nutraceutical peptides, promoting their inclusion in food systems aimed at health promotion and sustainability.
Indexed as
Identifiers
41116003What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.